Join Now

Free, anonymous support from people just like you.

We're on Facebook!
Check out our page!
DS Store is Open
DS t-shirts and more
Advertisement

cure4lupus
Female, 31, Omaha, NE
"Fighting Lupus"
10:52pm, December 4, 2008
October Newsletter Mood
Sunday, November 1, 2009

View our October 2009 Newsletter: http://cure4lupus.org/newsletters/newsletter1009.htm

 

Topics include: Vaccines & Lupus, A Better Doctor's Visit, Lupus Fundraisers, Cure4Lupus.org Moved, WeAreLupus.org, ButYouDontLookSick.com, Lupus Research News, What's Hot, Featured Product: 2009 Lupus Awareness Ornament, New and Updated pages.

 

Subscribe to the newsletter here: http://cure4lupus.org/phplist/?p=subscribe&id=6 

RATE THIS ENTRY:
Inspirational
Moving
Helpful
Creative

August Newsletter Mood
Wednesday, August 19, 2009

Read our August newsletter: http://cure4lupus.org/newsletters/newsletter809.htm

Topics Include:
Des Moines, IA Fundraiser,
Vitamin D & Lupus,
Donate to Our Walk Team,
BenLysta,
Featured Profile,
Featured Lupus Website,
Lupus Research News,
What's Hot,
Featured Product,
New and Updated Pages

Sign-up to get our newsletter by email: http://cure4lupus.org/phplist/?p=subscribe&id=6

RATE THIS ENTRY:
Inspirational
Moving
Helpful
Creative

Big News in Lupus Research Mood
Friday, July 24, 2009

This was a great week for Lupus research.  Human Genome Sciences, Inc. and GlaxoSmithKline PLC announced that BENLYSTA™ (belimumab, formerly LymphoStat-B®) met the primary endpoint in a 52 week study.  This is the first of two pivotal Phase 3 trials in patients with Systemic Lupus Erythematosus.  This was a placebo-controlled study in which BENLYSTA™ showed significant improvement of disease activity when compared to placebo with adverse reaction rates comparable to placebo.  The patients taking BENLYSTA™ were also able to reduce their steroid need.

BENLYSTA™ works by inhibiting BLyS.  BLyS is a protein required for B-lymphocytes to mature into plasma B cells.  Plasma B cells are white blood cells that produce antibodies and in Lupus they produce autoantibodies that attack the body's own tissues.  People with Lupus often have elevated BLyS levels. 

The results of the second, longer trial will be announced this fall.  If this trial is also successful and BENLYSTA™ gets FDA approval it will be the first new treatment for Lupus in over 50 years and the very first drug developed specifically for Lupus since it's discovery over a century ago.   

While a big step in the treatment of Lupus, this is only the beginning.  This is not a cure for Lupus.  Lupus is a complex, individualized disease that requires complex, individualized treatments.  Much more research and more treatments are needed.  BENLYSTA™'s success shows that there is hope and will hopefully help get some momentum going that will eventually lead to a cure!

RATE THIS ENTRY:
Inspirational
Moving
Helpful
Creative

Advertisement

Advertisement
Content on DailyStrength.org is for informational purposes only. We do not provide any medical advice, diagnosis or treatment. More info
Portions of support group and treatment information provided by Wikipedia under the GNU FDL license
Copyright 2006-2009, DailyStrength, Inc. All rights reserved.
Terms of Service | Privacy Policy | Report Abuse | HSW International | HSW China | HSW Brazil